Pre-operative combined modality therapy in the management of locally advanced rectal cancer

European Journal of Surgical Oncology

Volumn 32, Issue 3, 2006, Pages 259-268

  Ceelen, Wim ^a   Pattyn, P ^a   Boterberg, T ^a   Peeters, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cancer; Drug therapy; Radiotherapy; Rectal

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; RALTITREXED; TEGAFUR; URACIL;

ACCURACY; ACUTE TOXICITY; ADVANCED CANCER; ANORECTAL DISEASE; ANUS SPHINCTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; HUMAN; MULTIMODALITY CANCER THERAPY; ORGAN PRESERVATION; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RECTUM CANCER; RECTUM SURGERY; REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 33645062157     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.12.002     Document Type: Review

References (120)

1. R. Gray R. Hills R. Stowe M. Clarke R. Peto M. Buyse et al. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials Lancet 358 2001 1291-1304
2. L. Pahlman B. Glimelius B. Cedermark G. Lundell C. Rubio LE. Rutqvist et al. Improved survival with preoperative radiotherapy in resectable rectal cancer New Engl J Med 336 1997 980-987
3. P. Quirke M.F. Dixon P. Durdey NS. Williams Local recurrence of rectal adenocarcinoma due to inadequate surgical resection - histopathological study of lateral tumor spread and surgical excision Lancet 2 1986 996-999
4. R.J. Heald R.D.H. Ryall Recurrence and survival after total mesorectal excision for rectal-cancer Lancet 1 1986 1479-1482
5. J.K. Macfarlane R.D.H. Ryall R.J. Heald Mesorectal excision for rectal-cancer Lancet 341 1993 457-460
6. W.E. Enker H.T. Thaler M.L. Cranor T. Polyak Total mesorectal excision in the operative treatment of carcinoma of the rectum J Am Coll Surg 181 1995 335-346
7. A. Wibe B. Moller J. Norstein E. Carlsen JN. Wiig RJ. Heald et al. A national strategic change in treatment policy for rectal cancer implementation of total mesorectal excision as routine treatment in Norway. A national audit Dis Colon Rectum 45 2002 857-866
8. A.L. Martling T. Holm L.E. Rutqvist BJ. Moran RJ. Heald B. Cedermark et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm Lancet 356 2000 93-96
9. E. Kapiteijn C.A.M. Marijnen I.D. Nagtegaal H. Putter WH. Steup T. Wiggers et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer New Engl J Med 345 2001 638-646
10. C. Marijnen K. Peeters H. Putter E. Klein Kranenbarg A. Stiggelbout J. Leer et al. Long term results, toxicity and quality of life in the TME trial ASCO Gastrointestinal Cancers Symposium 2005 [abstract no. 166]
11. W.H. Steup Y. Moriya C.J.H. van de Velde Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases Eur J Cancer 38 2002 911-918
12. P.P. Tekkis A.G. Heriot J. Smith MR. Thompson P. Finan J.D Stamatakis Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer Colorectal Dis 7 2005 369-374
13. A.S. Allal S. Bierl A. Pelloni V. Spataro S. Anchisi P. Ambrosetti et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: Feasibility, oncologic results and quality of life outcomes Br J Cancer 82 2000 1131-1137
14. G.G. Steel M.J. Peckham Exploitable mechanisms in combined radiotherapy-chemotherapy - concept of additivity Int J Radiat Oncol 5 1979 85-91
15. P.R.M. Thomas A.S. Lindblad Adjuvant postoperative radiotherapy and chemotherapy in rectal-carcinoma - a review of the Gastrointestinal Tumor Study-Group experience Radiother Oncol 13 1988 245-252
16. [Anon]. Prolongation of the disease-free interval in surgically treated rectal-carcinoma. N Engl J Med 1985;312:1465-1472.
17. J.E. Krook C.G. Moertel L.L. Gunderson HS. Wieand RT. Collins RW. Beart et al. Effective surgical adjuvant therapy for high-risk rectal-carcinoma N Engl J Med 324 1991 709-715
18. W.H. Hall Adjuvant therapy for patients with colon and rectal-cancer JAMA 264 1990 1444-1450
19. B.D. Minsky A.M. Cohen N. Kemeny WE. Enker DP. Kelsen L. Saltz et al. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation-therapy for unresectable rectal-cancer Cancer 71 1993 3486-3492
20. B.D. Minsky A.M. Cohen W.E. Enker L. Saltz JG. Guillem PB. Paty et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer Int J Radiat Oncol 37 1997 289-295
21. A. de la Torre S. Ramos F.J. Valcarcel A. Candal CA. Regueiro J. Romero et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer Int J Radiat Oncol 45 1999 629-634
22. J.J. Tjandra D.M. Reading S.A. McLachlan IF. Gunn ND. Green SJ. McLaughlin et al. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer - preliminary results Dis Colon Rectum 44 2001 1113-1122
23. C.G. Moertel D.S. Childs R.J. Reitemeier MY. Colby MA. Holbrook Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 2 1969 865-867
24. C.J. Rominger R.D. Gelber L.L. Gunderson N. Conner Radiation-therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery - Radiation-Therapy Oncology Group-Study (76-16) Am J Clin Oncol Cancer Clin Trials 8 1985 118-127
25. M. Overgaard K. Bertelsen M. Dalmark CC. Gadeberg H. Vondermaase J. Overgaard et al. A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal-carcinoma Acta Oncol 32 1993 547-553
26. G.J. Frykholm L. Pahlman B. Glimelius Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum Int J Radiat Oncol 50 2001 427-434
27. S. Ngan R. Fisher B.H. Burmeister D. Joseph M. Solomon J. Mackay et al. 55th Annual Scientific Meeting of the Royal Australian and New Zealand College of Radiologists, 21-24 October 2004, Perth, Australia Australas Radiol 49 2005 A1-A6
28. B. Glimelius Radiotherapy in rectal cancer Br Med Bull 64 2002 141-157
29. B. Glimelius U. Isacsson Preoperative radiotherapy for rectal cancer - is 5 × 5 Gy a good or a bad schedule? Acta Oncol 40 2001 958-967
30. T. Holm T. Singnomklao L.E. Rutqvist B. Cedermark Adjuvant preoperative radiotherapy in patients with rectal carcinoma - adverse effects during long term follow-up of two randomized trials Cancer 78 1996 968-976
31. M. Dahlberg B. Glimelius W. Graf L. Pahlman Preoperative irradiation affects functional results after surgery for rectal cancer - results from a randomized study Dis Colon Rectum 41 1998 543-549
32. K. Peeters C.J.H. van de Velde J.W.H. Leer H. Martijn JMC. Junggeburt EK. Kranenbarg et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - a Dutch Colorectal Cancer Group Study J Clin Oncol 23 2005 6199-6206
33. C.A.M. Marijnen C.J.H. van de Velde H. Putter M. van den Brink CP. Maas H. Martijn et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial J Clin Oncol 23 2005 1847-1858
34. Y. Francois C.J. Nemoz J. Baulieux J. Vignal JP. Grandjean C. Partensky et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial J Clin Oncol 17 1999 2396-2402
35. H.G. Moore A.E. Gittleman B.D. Minsky D. Wong PB. Paty M. Weiser Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection Dis Colon Rectum 47 2004 279-286
36. C.A.M. Marijnen I.D. Nagtegaal E. Kapiteijn EK. Kranenbarg EM. Noordijk J. van Krieken et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial Int J Radiat Oncol 55 2003 1311-1320
37. I.R. Daniels MRI predicts surgical resection margin status in patients with rectal cancer: Results from the MERCURY study Dis Colon Rectum 48 2005 686
38. R.G.H. Beets-Tan G.L. Beets Rectal cancer: How accurate can imaging predict the T stage and the circumferential resection margin? Int J Colorectal Dis 18 2003 385-391
39. C. Roedel R. Fietkau R. Raab C. Wittekind P. Martus R. Sauer Tumor regression grading as prognostic factor in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy Int J Radiat Oncol 60 2004 S140
40. J. Vironen M. Juhola M. Kairaluoma I. Jantunen I. Kellokumpu Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma Int J Colorectal Dis 20 2005 440-445
41. M. Mohiuddin M. Hayne W.F. Regine N. Hanna PF. Hagihara P. McGrath et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol 48 2000 1075-1080
42. N.A. Janjan C. Crane B.W. Feig K. Cleary R. Dubrow S. Curley et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer Am J Clin Oncol Cancer Clin Trials 24 2001 107-112
43. G. Theodoropoulos W.E. Wise A. Padmanabhan BA. Kerner CW. Taylor PS. Aguilar et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival Dis Colon Rectum 45 2002 895-903
44. J. Garcia-Aguilar E.H. de Anda P. Sirivongs SH. Lee RD. Madoff DA. Rothenberger A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 2003 298-304
45. V. Valentini C. Coco A. Picciocchi AG. Morganti L. Trodella A. Ciabattoni et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol 53 2002 664-674
46. S. Pucciarelli P. Toppan M.L. Friso V. Russo L. Pasetto E. Urso et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome Dis Colon Rectum 47 2004 1798-1807
47. M.W. Onaitis R.B. Noone R. Fields H. Hurwitz M Morse P Jowell et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival Ann Surg Oncol 8 2001 801-806
48. R.P.M. Saw M. Morgan D. Koorey D Painter M Findlay G Stevens et al. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy Dis Colon Rectum 46 2003 192-202
49. F. Prall C. Ostwald H. Nizze M Barten Expression profiling of colorectal carcinomas using tissue microarrays: Cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysis Appl Immunohist Mol Morphol 12 2004 111-121
50. H.J. Chang K.H. Jung D.Y. Kim SY Jeong HS Choi YH Kim et al. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma Hum Pathol 36 2005 364-371
51. B.M. Ghadimi M. Grade M.J. Difilippantonio S Varma R Simon C Montagna et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy J Clin Oncol 23 2005 1826-1838
52. H. Amthauer T. Denecke B. Rau B Hildebrandt M Hunerbein J Ruf et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology Eur J Nucl Med Mol Immunol 31 2004 811-819
53. A.F. DeVries C. Kremser P.A. Hein J Griebel A Krezcy D Ofner et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma Int J Radiat Oncol 56 2003 958-965
54. A. Habr-Gama R.O. Perez W. Nadalin J Sabbaga U Ribeiro A Sousa et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - long-term results Ann Surg 240 2004 711-717
55. J.G. Guillem D.B. Chessin J. Shia HG Moore M Mazumdar B Bernard et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point J Clin Oncol 23 2005 3475-3479
56. S.P. Hiotis S.M. Weber A.M. Cohen BD Minsky PB Paty JG Guillem et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients J Am Coll Surg 194 2002 131-135
57. C. Capirci D. Rubello F. Chierichetti G Crepaldi A Carpi A Nicolini et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: Role of F18-FDG PET Biomed Pharmacother 58 2004 451-457
58. S. Meterissian J. Skibber T. Rich L Roubein J Ajani K Cleary et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3-rectal carcinoma Ann Surg Oncol 1 1994 111-116
59. O. Zmora G.M. Dasilva B. Gurland R Pfeffer M Koller JJ Nogueras et al. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Dis Colon Rectum 47 2004 1607-1612
60. F. Stipa A. Zernecke H.G. Moore BD Minsky WD Wong M Weiser et al. Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: Rationale for radical resection? Ann Surg Oncol 11 2004 187-191
61. W.T. Nakagawa B.M. Rossi F.D. Ferreira R Ferrigno WJ David IN Nishimoto et al. Chemoradiation instead of surgery to treat mid and low rectal tumors: Is it safe? Ann Surg Oncol 9 2002 568-573
62. C. Montesani A. Pronio S. Santella A Boschetto D Aguzzi R Pirozzi et al. Rectal cancer surgery with sphincter preservation: Functional results related to the level of anastomosis. Clinical and instrumental study Hepatogastroenterology 51 2004 718-721
63. P. van Duijvendijk J.F.M. Slors C.W. Taat WF van Tets G van Tienhoven H Obertop et al. Prospective evaluation of anorectal function after total mesorectal excision for rectal carcinoma with or without preoperative radiotherapy Am J Gastroenterol 97 2002 2282-2289
64. J.M.D. Wheeler B.F. Warren A.C. Jones NJM Mortensen Preoperative radiotherapy for rectal cancer: Implications for surgeons, pathologists and radiologists Br J Surg 86 1999 1108-1120
65. J. Feliu J. Calvillo A. Escribano J de Castro ME Sanchez A Mata et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy Ann Oncol 13 2002 730-736
66. J.F. Bosset V. Magnin P. Maingon G Mantion EP Pelissier M Mercier et al. Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial Int J Radiat Oncol 46 2000 323-327
67. K. Ammann W. Kirchmayr A. Klaus G Muhlmann R Kafka M Oberwalder et al. Impact of neoadjuvant chemoradiation on anal sphincter function in patients with carcinoma of the midrectum and low rectum Arch Surg 138 2003 257-261
68. M. Mercier P. Pasquet M. Puyraveau J Bosset G Calais L Mineur et al. Evaluation of the sphincter function and quality of life in French patients with rectal cancer who entered the EORTC 22921 study Eur J Cancer 2 Suppl 3 2005 171
69. C.G. Willett D. Chung D. Sahani M Mino J Clark D Ryan et al. Phase I study of neoadjuvant bevacizumab, 5-fluorouracil, and radiation therapy followed by surgery for patients with primary rectal cancer J Clin Oncol 22 2004 267s
70. S. Patel T. Vuong O. Ballivy L Portelance W Parker H. Patrocinio Intensity-modulated radiotherapy (IMRT) reduces acute toxicity in the treatment of rectal cancer: Results of a phase II study Radiother Oncol 72 2004 S33
71. W. Duthoy W. De Gersem K. Vergote T Boterberg C Derie P Smeets et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer Int J Radiat Oncol 60 2004 794-806
72. M.M. Kligerman Preoperative radiation-therapy in rectal cancer Cancer 36 1975 691-695
73. A. Gerard M. Buyse B. Nordlinger J Loygue F Pene P Kempf et al. Preoperative radiotherapy as adjuvant treatment in rectal-cancer - final results of a randomized study of the European Organization for Research and Treatment of Cancer (Eortc) Ann Surg 208 1988 606-614
74. G.D. Oates S.P. Stenning J.D. Hardcastle WAF McAdam MG Greaney A Gunn et al. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer Lancet 348 1996 1605-1610
75. P.J. Marsh R.D. James P.F. Schofield Adjuvant preoperative radiotherapy for locally advanced rectal-carcinoma - results of a prospective, randomized trial Dis Colon Rectum 37 1994 1205-1214
76. B. Cedermark H. Johansson L.E. Rutqvist N Wilking The Stockholm-I trial of preoperative short-term radiotherapy in operable rectal-carcinoma - a prospective randomized trial Cancer 75 1995 2269-2275
77. G. Klautke P. Feyerherd K. Ludwig F Prall T Foitzik R Fietkau Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer Br J Cancer 92 2005 1215-1220
78. M.F. Osti M. Valeriani L. Masoni V Tombolini RM Enrici Neoadjuvant chemoradiation for locally advanced carcinoma of the rectum Tumori 90 2004 303-309
79. M.A. Gambacorta V. Valentini C. Coco AG Morganti D Smaniotto F Micciche et al. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies Int J Radiat Oncol 60 2004 139-148
80. M.A. Gambacorta V. Valentini A.G. Morganti G Mantini F Micciche C Ratto et al. Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study Int J Radiat Oncol 60 2004 130-138
81. C. Fernandez-Martos J. Aparicio C. Bosch M Torregrosa JM Campos S Garcera et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up J Clin Oncol 22 2004 3016-3022
82. A. Ciabattoni A. Cavallaro A.E. Potenza R Colli F Maurizi F Micciche et al. Preoperative concomitant radiochemotherapy with a 5-fluorouracil plus folinic acid bolus in the combined treatment of locally advanced extraperitoneal rectal cancer: A long-term analysis on 27 patients Tumori 89 2003 157-163
83. J.P. Gerard O. Chapet C. Nemoz P Romestaing F Mornex R Coquard et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The lyon R0-04 phase II trial J Clin Oncol 21 2003 1119-1124
84. I. Chau M. Allen D. Cunningham D Tait G Brown M Hill et al. Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer Br J Cancer 88 2003 1017-1024
85. V.K. Mehta C. Cho J.M. Ford C Jambalos J Poen A Koong et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer Int J Radiat Oncol 55 2003 132-137
86. F. Grillo-Ruggieri G. Mantello M. Cardinali L Fabbietti F Fenu M Montisci et al. Down-staging after two different preoperative chemoradiation schedules in rectal cancer Tumori 89 2003 164-167
87. C. Rodel G.G. Grabenbauer T. Papadopoulos W Hohenberger HJ Schmoll R Sauer Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 21 2003 3098-3104
88. F. Bozzetti S. Andreola D. Baratti L Mariani SC Stani F Valvo et al. Preoperative chemoradiation in patients with resectable rectal cancer: results on tumor response Ann Surg Oncol 9 2002 444-449
89. J.S. Kim J.S. Kim M.J. Cho KS Song WH Yoon Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol 54 2002 403-408
90. M. Schaffer M. Thoma R. Wilkowski P Schaffer E Duhmke Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity Onkologie 25 2002 352-356
91. F.A. Calvo M. Gomez-Espi J.A. Diaz-Gonzalez R Cantalapiedra P Marcos A Alvarado et al. Pathologic downstaging of T3-4NX rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur Int J Radiat Oncol 51 2001 1264-1270
92. P. Luna-Perez S. Rodriguez-Ramirez D.F. Rodriguez-Coria A Fernandez S Labastida A Silva et al. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma World J Surg 25 2001 1006-1011
93. S.Y.K. Ngan B.H. Burmeister R. Fisher D Rischin DJ Schache A Kneebone et al. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: A phase II trial for the Trans-Tasman Radiation Oncology Group Int J Radiat Oncol 50 2001 883-887
94. M.W. Onaitis R.B. Noone M. Hartwig H Hurwitz M Morse P Jowell et al. Neoadjuvant chemoradiation for rectal cancer: Analysis of clinical outcomes from a 13-year institutional experience Ann Surg 233 2001 778-785
95. B. Kuvshinoff I. Maghfoor B. Miedema M Bryer S Westgate J Wilkes et al. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: Are ≤1 cm distal margins sufficient? Ann Surg Oncol 8 2001 163-169
96. A. Grann C. Feng D. Wong L Saltz PP Paty JG Guillem et al. Preoperative combined modality therapy for clinically resectable UT3 rectal adenocarcinoma Int J Radiat Oncol 49 2001 987-995
97. U. Kuchenmeister R. Kirchner J. Mellert G Klautke R Mucke UT Hopt et al. First results of concurrent preoperative radiochemotherapy of locally advanced rectal canter Strahlenther Onkol 176 2000 560-566
98. N.P. Nguyen S. Sallah U. Karlsson A Ludin P Vos P Lepera et al. Combined preoperative chemotherapy and radiation for locally advanced rectal carcinoma Am J Clin Oncol Cancer Clin Trials 23 2000 442-448
99. N.A. Janjan C.N. Crane B.W. Feig K Cleary R Dubrow SA Curley et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer Int J Radiat Oncol 47 2000 713-718
100. S. Pucciarelli M.L. Friso P. Toppan A Fornasiero S Carnio E Marchiori et al. Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: Preliminary results Ann Surg Oncol 7 2000 38-44
101. N.A. Janjan V.S. Khoo J. Abbruzzese R Pazdur R Dubrow KR Cleary et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation ln locally advanced rectal cancer: The M.D. Anderson Cancer Center experience Int J Radiat Oncol 44 1999 1027-1038
102. M.C. Kaminsky-Forrett T. Conroy E. Luporsi D Peiffert M Lapeyre P Boissel et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer Int J Radiat Oncol 42 1998 935-941
103. P.G. Meade G.J. Blatchford A.G. Thorson MA Christensen CA Ternent Preoperative chemoradiation downstages locally advanced ultrasound-stage rectal-cancer Am J Surg 170 1995 609-613
104. T.A. Rich J.M. Skibber J.A. Ajani DJ Buchholz KR Cleary RA Dubrow et al. Preoperative infusional chemoradiation therapy for stage T3 rectal-cancer Int J Radiat Oncol 32 1995 1025-1029
105. A. Picciocchi C. Coco P. Magistrelli G Roncolini G Netri C Mattana et al. Concomitant preoperative radiochemotherapy in operable locally advanced rectal-cancer Dis Colon Rectum 37 1994 S69-S72
106. E.T. Chen M. Mohiuddin H. Brodovsky G Fishbein G Marks Downstaging of advanced rectal-cancer following combined preoperative chemotherapy and high-dose radiation Int J Radiat Oncol 30 1994 169-175
107. J.C. Landry M.J. Koretz W.C. Wood S Bahri RG Smith M Costa et al. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma - phase I-Ii Study Radiology 188 1993 423-426
108. A. Chan A. Wong J. Langevin R Khoo Preoperative concurrent 5-fluorouracil infusion, mitomycin-C and pelvic radiation-therapy in tethered and fixed rectal-carcinoma Int J Radiat Oncol 25 1993 791-799
109. M. Haghbin B. Sischy J. Hinson Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma Radiother Oncol 13 1988 75-81
110. G.D. Weinstein T.A. Rich C.R. Shumate JM Skibber KR Cleary JA Ajani et al. Preoperative infusional chemoradiation and surgery with or without an electron-beam intraoperative boost for advanced primary rectal-cancer Int J Radiat Oncol 32 1995 197-204
111. X.N. Sun Q.C. Yang J.B. Hu Pre-operative radiochemotherapy of locally advanced rectal cancer World J Gastroenterol 9 2003 717-720
112. C.H. Crane J.M. Skibber E.H. Birnbaum BW Feig AK Singh ME Delclos et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer Int J Radiat Oncol 57 2003 84-89
113. S. Bouliswassif A. Gerard J. Loygue D Camelot M Buyse N Duez Final results of a randomized trial on the treatment of rectal-cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery - trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Cancer 53 1984 1811-1818
114. K. Bujko M.P. Nowacki A. Nasierowska-Guttmejer W Michalski AB Bebenek A Pudelko et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15-24
115. J-P. Gerard F. Bonnetain T. Conroy O Chapet O Bouche M Closon-Dejardin et al. Preoperative radiotherapy ±5FU/folinic acid in T3-4 rectal cancers: Result of the FFCD 9203 randomized trial J Clin Oncol 23 2005 247s [Abstract 3504]
116. J. Bosset G. Calais L. Mineur P Maingon L Radosevic-Jelic A Daban et al. Preoperative radiation in rectal cancer: Effect and timing of additional chemotherapy 5-year results of the EORTC 22921 trial J Clin Oncol 23 2005 247s [Abstract 3505]
117. J.F. Bosset G. Calais L. Mineur P Maingon L Radosevic-Jelic A Daban et al. Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer: Report of the 22921 EORTC phase III trial J Clin Oncol 22 2004 246S
118. R. Sauer H. Becker W. Hohenberger C Rodel C Wittekind R Fietkau et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer New Engl J Med 351 2004 1731-1740
119. D.M. Hyams E.P. Mamounas N. Petrelli H Rockette J Jones HS Wieand et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum - a progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03 Dis Colon Rectum 40 1997 131-139
120. M.S. Roh N. Petrelli S. Wieand L Colangelo R Smith EP Mamounas et al. Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03) Proc ASCO 19 2001 490 [Abstract]